CE: Review of Human Immunodeficiency Virus and Updated Guidelines

Erica Hagen


HIV is a challenging diagnosis for patients with many lifelong implications. It was once a disease state that was associated with a relatively short life expectancy. However, as new drugs have been developed the outcomes have improved drastically. As a healthcare team, it is a duty to keep up with new treatments and therapies that will improve the lives of patients. The HIV/AIDS guidelines are updated regularly, and the most current updated portions are highlighted for easy differentiation. This review will cover some of the updates that occurred in July 2016 and provide a background on the disease state. 

Full Text:



  • There are currently no refbacks.

Notice and Disclaimer

Medicine is an ever-changing science.  As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required.  The authors and the publisher of this work have checked with sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication.  However, in view of the possibility of human error or changes in medical sciences, neither the authors nor the publisher nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is accurate or complete, and they disclaim all responsibility for any errors or omissions or for the results obtained from use of the information contained in this work.    Readers are encouraged to confirm the information contained herein with other sources.   For example and in particular, readers are advised to check the product information sheet included in the package of each drug they plan to administer to be certain that the information contained in this work is accurate and that changes have not been made in the recommended dose or in the contraindications for administration.